Article
Tumour heterogeneity and immune-modulation
7 May 2013
Abstract excerpt
Recent advances in sequencing technologies have revealed extensive intratumour heterogeneity (ITH) both within individual tumours and between primary and metastatic tumours for different cancer types. Such genetic diversity may have clinical implications for both cancer diagnosis and treatment with increasing evidence linking ITH and therapeutic resistance. Nonetheless, whilst limiting the activity of targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
